Vident Investment Advisory’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,694
| Closed | -$209K | – | 1232 |
|
|
2021
Q2 | $209K | Sell |
2,694
-3,483
| -56% | -$270K | 0.01% | 1042 |
|
|
2021
Q1 | $460K | Sell |
6,177
-1,787
| -22% | -$133K | 0.02% | 811 |
|
|
2020
Q4 | $1.36M | Buy |
7,964
+432
| +6% | +$73.7K | 0.06% | 445 |
|
|
2020
Q3 | $1.06M | Buy |
7,532
+1,574
| +26% | +$221K | 0.05% | 471 |
|
|
2020
Q2 | $955K | Buy |
5,958
+3,554
| +148% | +$570K | 0.05% | 492 |
|
|
2020
Q1 | $235K | Buy |
2,404
+207
| +9% | +$20.2K | 0.02% | 729 |
|
|
2019
Q4 | $284K | Buy |
+2,197
| New | +$284K | 0.02% | 647 |
|
|
2019
Q2 | – | Sell |
-1,964
| Closed | -$234K | – | 625 |
|
|
2019
Q1 | $234K | Sell |
1,964
-593
| -23% | -$70.7K | 0.01% | 683 |
|
|
2018
Q4 | $279K | Sell |
2,557
-160
| -6% | -$17.5K | 0.02% | 724 |
|
|
2018
Q3 | $439K | Buy |
+2,717
| New | +$439K | 0.02% | 745 |
|